Patten & Patten’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,502
Closed -$1.11M 267
2022
Q3
$1.11M Buy
4,502
+182
+4% +$49.1K 0.1% 129
2022
Q2
$1.07M Buy
4,320
+297
+7% +$80.1K 0.09% 137
2022
Q1
$1.33M Buy
4,023
+504
+14% +$155K 0.1% 132
2021
Q4
$1.26M Buy
3,519
+243
+7% +$82.1K 0.09% 135
2021
Q3
$1.07M Buy
3,276
+356
+12% +$121K 0.08% 143
2021
Q2
$911K Buy
2,920
+70
+2% +$21.5K 0.07% 164
2021
Q1
$908K Sell
2,850
-7
-0.2% -$2.24K 0.07% 156
2020
Q4
$926K Buy
2,857
+5
+0.2% +$1.38K 0.08% 148
2020
Q3
$790K Hold
2,852
0.08% 147
2020
Q2
$689K Hold
2,852
0.08% 152
2020
Q1
$414K Buy
+2,852
New +$473K 0.05% 170

Other funds holding ABMD

Patten & Patten's ABMD Position: Q4 2022 in Review

Patten & Patten sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,502 shares — an estimated $1.11M sold.

Patten & Patten first reported a position in ABMD in Q1 2020 and held it in 11 quarters. The position peaked at $1.33M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Patten & Patten reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Patten & Patten sold 4,502 Abiomed Inc shares in Q4 2022, an estimated $1.11M.
  • Patten & Patten first reported a position in Abiomed Inc in Q1 2020 and held it in 11 quarters.
  • Patten & Patten's Abiomed Inc position peaked at $1.33M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Patten & Patten's 13F filing for Q4 2022, filed 1 Feb 2023.